Inovalon Holdings, Inc., a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company's platform enables the assessment and enhancement of clinical and quality outcomes and financial performance. It serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. The company provides technology that supports approximately 500 healthcare organizations. Its platforms are informed by data pertaining to approximately 932,000 physicians; 455,000 clinical facilities; and approximately 240 million individuals and 37 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Data processing & preparation
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:INOV
Previous Symbol
CUSIPN/A
Phone301-809-4000
Debt
Debt-to-Equity Ratio1.36
Current Ratio2.07
Quick Ratio2.07
Price-To-Earnings
Trailing P/E Ratio57.04
Forward P/E Ratio59.64
P/E Growth4.52
Sales & Book Value
Annual Sales$449.36 million
Price / Sales4.45
Cash Flow$0.5704 per share
Price / Cash Flow23.00
Book Value$4.47 per share
Price / Book2.94
Profitability
EPS (Most Recent Fiscal Year)$0.23
Net Income$34.81 million
Net Margins-2.12%
Return on Equity4.12%
Return on Assets1.90%
Miscellaneous
Employees2,480
Outstanding Shares152,410,000
Market Cap$2.10 billion
OptionableOptionable
Inovalon (NASDAQ:INOV) Frequently Asked Questions
What is Inovalon's stock symbol?
Inovalon trades on the NASDAQ under the ticker symbol "INOV."
How were Inovalon's earnings last quarter?
Inovalon Holdings Inc (NASDAQ:INOV) announced its earnings results on Wednesday, November, 7th. The technology company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by $0.01. The technology company had revenue of $145.81 million for the quarter, compared to the consensus estimate of $159.53 million. Inovalon had a positive return on equity of 4.12% and a negative net margin of 2.12%. The firm's revenue for the quarter was up 25.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.09 EPS. View Inovalon's Earnings History.
When is Inovalon's next earnings date?
What guidance has Inovalon issued on next quarter's earnings?
Inovalon issued an update on its FY19 earnings guidance on Wednesday, November, 7th. The company provided earnings per share (EPS) guidance of $0.41-0.47 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.43. The company issued revenue guidance of $637-657 million, compared to the consensus revenue estimate of $647.06 million.Inovalon also updated its FY 2018 guidance to $0.27-0.34 EPS.
What price target have analysts set for INOV?
2 Wall Street analysts have issued 1 year price objectives for Inovalon's stock. Their forecasts range from $10.00 to $11.00. On average, they expect Inovalon's share price to reach $10.50 in the next twelve months. This suggests that the stock has a possible downside of 20.0%. View Analyst Price Targets for Inovalon.
What is the consensus analysts' recommendation for Inovalon?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 1 sell rating and 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inovalon.
Has Inovalon been receiving favorable news coverage?
Headlines about INOV stock have been trending negative on Tuesday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Inovalon earned a daily sentiment score of -2.4 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the immediate future.
Who are some of Inovalon's key competitors?
Some companies that are related to Inovalon include RingCentral (RNG), Zendesk (ZEN), StoneCo (STNE), Proofpoint (PFPT), Bilibili (BILI), YY (YY), Pegasystems (PEGA), CarGurus (CARG), Zynga (ZNGA), Corelogic (CLGX), PagSeguro Digital (PAGS), Five9 (FIVN), Trivago (TRVG), Evertec (EVTC) and Globant (GLOB).
Who are Inovalon's key executives?
Inovalon's management team includes the folowing people:
- Keith R. Dunleavy, Chairman & CEO (Age 49)
- Mr. Robert A. Wychulis, Pres (Age 63)
- Mr. John Michael Burgin, Chief Product Officer (Age 44)
- Mr. Jonathan R. Boldt, Interim Chief Financial Officer (Age 33)
- Mr. Jason B. Capitel, Chief Operating Officer (Age 46)
When did Inovalon IPO?
(INOV) raised $500 million in an initial public offering on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.
Who are Inovalon's major shareholders?
Inovalon's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (3.93%), Vanguard Group Inc (3.93%), BlackRock Inc. (3.36%), FMR LLC (3.15%), Neuberger Berman Group LLC (2.40%) and Riverbridge Partners LLC (0.64%). Company insiders that own Inovalon stock include Jason Capitel, Joseph R Rostock, Keith R Dunleavy, Lee D Roberts, Robert A Wychulis and Shauna L Vernal. View Institutional Ownership Trends for Inovalon.
Which institutional investors are selling Inovalon stock?
INOV stock was sold by a variety of institutional investors in the last quarter, including Senvest Management LLC, Neuberger Berman Group LLC, Renaissance Technologies LLC, AQR Capital Management LLC, JPMorgan Chase & Co., Riverbridge Partners LLC, Bank of New York Mellon Corp and TIAA CREF Investment Management LLC. View Insider Buying and Selling for Inovalon.
Which institutional investors are buying Inovalon stock?
INOV stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Tekla Capital Management LLC, Vanguard Group Inc, Vanguard Group Inc., Citadel Advisors LLC, FMR LLC, MetLife Investment Advisors LLC and Oppenheimer Asset Management Inc.. Company insiders that have bought Inovalon stock in the last two years include Jason Capitel, Keith R Dunleavy and Lee D Roberts. View Insider Buying and Selling for Inovalon.
How do I buy shares of Inovalon?
Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Inovalon's stock price today?
One share of INOV stock can currently be purchased for approximately $13.12.
How big of a company is Inovalon?
Inovalon has a market capitalization of $2.10 billion and generates $449.36 million in revenue each year. The technology company earns $34.81 million in net income (profit) each year or $0.23 on an earnings per share basis. Inovalon employs 2,480 workers across the globe.
What is Inovalon's official website?
How can I contact Inovalon?
Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]
MarketBeat Community Rating for Inovalon (NASDAQ INOV)
MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote "Outperform" if you believe INOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days.
